PDA-Based Nanoplatform with High Ligustilide Loading for Simultaneous Elimination of Breast Cancer Cells and Stem Cells Via BAX/BCL-2/Caspase-3 Pathway Activation
ACS Applied Bio Materials · 16.06.2026
DOI: 10.1021/acsabm.6c00384 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 16.06.2026. Verfasst von Wenjing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, State Key Laboratory of Green Biomanufacturing, Innovation Center of Molecular Diagnostics, Beijing Universit…. Hauptthemen laut MEDLINE: 4-Butyrolactone, Antineoplastic Agents, Breast Neoplasms, Biocompatible Materials. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Technology, State Key Laboratory of Green Biomanufacturing, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing 100029, China.
- State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
ORCID-Profile: Heyun Shen, Zhao Yang
Förderung
- Key Technologies Research and Development Program
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- ?Open Competition to Select the Best Candidates? Key Technology Program for Nucleic Acid Drugs of NCTIB
Zitieren
APA
Zhang, W., Chen, X., Lin, Z., Pan, S., Sabeel, Z., Li, W., Shen, H., & Yang, Z. (2026). PDA-Based Nanoplatform with High Ligustilide Loading for Simultaneous Elimination of Breast Cancer Cells and Stem Cells Via BAX/BCL-2/Caspase-3 Pathway Activation. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00384
Vancouver
Zhang W, Chen X, Lin Z, Pan S, Sabeel Z, Li W, et al. PDA-Based Nanoplatform with High Ligustilide Loading for Simultaneous Elimination of Breast Cancer Cells and Stem Cells Via BAX/BCL-2/Caspase-3 Pathway Activation. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00384
BibTeX
@article{Zhang2026,
author = {Zhang, Wenjing and Chen, Xiaoyang and Lin, Ziyi and Pan, Shangyang and Sabeel, Zufa and Li, Wenxin and Shen, Heyun and Yang, Zhao},
title = {PDA-Based Nanoplatform with High Ligustilide Loading for Simultaneous Elimination of Breast Cancer Cells and Stem Cells Via BAX/BCL-2/Caspase-3 Pathway Activation},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00384}
}
EUVIMED